0000000000787229

AUTHOR

Rosario Garcia Campelo

showing 4 related works from this author

First analysis of the National Lung Cancer Register in Spain (RTT).

2018

e13608Background: The Spanish Lung Cancer Group (GECP) initiated a Tumor Thoracic Register (RTT) in September 2016 with the aim of evaluating accurate, basic data concerning this oncological pathol...

congenital hereditary and neonatal diseases and abnormalitiesCancer Researchmedicine.medical_specialtyintegumentary systemOncologyRegister (music)business.industryInternal medicinemedicineLung cancermedicine.diseasebusinessJournal of Clinical Oncology
researchProduct

Clinical utility of plasma-based digital next-generation sequencing (NGS) in patients with advance-stage lung adenocarcinomas with insufficient tumor…

2018

9101Background: Approximately 20 % of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. In this study, we have anal...

OncologyCancer Researchmedicine.medical_specialtyLungbusiness.industryDNA sequencingSubtypingInsufficient Tissuemedicine.anatomical_structureOncologyInternal medicineMedicineIn patientStage (cooking)businessGenotypingJournal of Clinical Oncology
researchProduct

Development of an MCDA framework for evaluation and positioning of oncological treatments in clinical practice.

2019

95 Background: Ensuring that effective innovations are accessible in a timely and affordable manner to all cancer patients is a challenge that stakeholders face today. Several oncology frameworks (ASCO, ESMO, ICER, NCCN) have been developed to define and quantify the value of oncological therapies to support clinicians and patients at the time of selection and as a basis for decision-making. However, current frameworks only define treatment value in terms of clinical benefit, creating a need for one that allows holistic evaluation of treatments and supports decision-making in clinical practice. The ECO Foundation led this study to develop a reflective multi-criteria decision analysis (MCDA…

Clinical PracticeCancer Researchmedicine.medical_specialtyOncologybusiness.industryMedicineCancerMedical physicsMultiple-criteria decision analysisbusinessmedicine.diseaseJournal of Clinical Oncology
researchProduct

Determination of essential biomarkers in lung cancer: a real-world data study in Spain.

2022

Abstract Background: The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself. This work aims to study the situation of biomarker testing in Spain.Patients and Methods: The Thoracic Tumours Registry (TTR) is an observational, prospective, registry-based study that included patients diagnosed with lung cancer and other thoracic tumours, from September 2016 to 2020. This TTR study was sponsored by the Spanish Lung Cancer Group (GECP) Foundation, an independent, scientific, multidisciplinary oncology society that coordinate…

Càncer
researchProduct